Some clinical guidelines recommended a basal insulin regimen as the initiation insulin therapy for hyperglycemia in non-critically ill patients (10, 12), whereas a premixed insulin formulation is also a most frequently prescribed treatment for patients with T2DM in many regions in Asia, Europe, and Latin America (8, 9, 11). Here, INS is linked to Hyperglycemia.